A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)
Public ClinicalTrials.gov record NCT07862595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Analgesic Effects and Safety of MK-6916 for Acute Pain Following Bunionectomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Researchers are looking for new treatments for pain. While there are many approved treatments for pain, the treatments do not work well for everyone. People can also become addicted to certain pain medicines. Researchers designed a trial medicine called MK-6916 to treat pain. The goal of the trial is to learn if at least 1 dose of MK-6916 works better than placebo to lessen pain. A placebo looks like the trial medicine but has no trial medicine in it. Using a placebo helps researchers better understand the effects of the trial medicine.
Study identification
- NCT ID
- NCT07862595
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 380 participants
Conditions and interventions
Conditions
Interventions
- MK-6916 Drug
- Hydrocodone/acetaminophen (HB/APAP) Drug
- MK-6916 Placebo Drug
- Rescue Medication Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 23, 2026 (Estimated)
- Primary completion
- Jun 10, 2027 (Estimated)
- Completion
- Jun 10, 2027 (Estimated)
- Last update posted
- Nov 6, 2026
2026 – 2027
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Pharmacology of Miami ( Site 0718) | Miami | Florida | 33172 | — |
| ForCare Clinical Research ( Site 0705) | Tampa | Florida | 33613 | — |
| Atlanta Center for Medical Research ( Site 0708) | Atlanta | Georgia | 30331 | — |
| Gateway Clinical Trails, Llc ( Site 0701) | O'Fallon | Illinois | 62269 | — |
| Legent Orthopedic & Spine Hospital ( Site 0711) | Bellaire | Texas | 77401 | — |
| Memorial Hermann Village ( Site 0704) | Houston | Texas | 77043 | — |
| Futuro Clinical Trials ( Site 0703) | McAllen | Texas | 78501 | — |
| Endeavor Clinical Trials PA ( Site 0700) | San Antonio | Texas | 78240 | — |
| JBR Clinical Research ( Site 0702) | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07862595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2026 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07862595 live on ClinicalTrials.gov.